Ren et al. (2010) found that Tanshinone IIA effectively suppresses the release of inflammatory factors following myocardial infarction by reducing the expression of monocyte chemoattractant protein-1 (MCP-1), thereby decreasing the infiltration of inflammatory cells. This evidence concerns the gene CCL2 and myocardial infarction.